Acquisition and Other Expense

6 Months Ended

Jun. 30, 2021

Acquisition and Other Expense [Abstract]

Acquisition and other expense consist of the following, which are included in cost of sales or selling and administrative expense depending on the nature of the charge:


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020


Plant underutilization costs	$	—	$	6,586	$	—	$	6,586
Product rationalization costs - inventory	—		2,169		—		2,169
Restructuring costs	—		1,087		—		1,087
Manufacturing consolidation costs	—		1,602		—		3,387
Acquisition and integration costs	—		652		—		1,457
Acquisition and other expense included in cost of sales	$	—	$	12,096	$	—	$	14,686


Restructuring and related costs	$	—	$	2,124	$	414	$	2,124
Product rationalization costs - field inventory	—		2,095		—		2,095
Acquisition and integration costs	—		439		—		1,192
Acquisition and other expense included in selling and administrative expense	$	—	$	4,658	$	414	$	5,411

During the second quarter of 2020, we recorded a $6.6 million charge to cost of sales related to plant underutilization due to abnormally low production as a result of decreased sales caused by the COVID-19 pandemic.

During the second quarter of 2020, we performed an analysis of our product lines and determined certain catalog numbers, principally related to capital equipment, would be discontinued and consolidated into existing product offerings. We consequently recorded a $2.2 million charge to cost of sales to write-off inventory of the discontinued products. In addition, we incurred $2.1 million in costs related to the write-off of field inventory used for customer demonstration and evaluation of the discontinued products which we charged to selling and administrative expense.

During the second quarter of 2020, we incurred $1.1 million in restructuring costs related to a voluntary separation arrangement with employees as a result of the COVID-19 pandemic that were charged to cost of sales based on the job function of the affected employees. We additionally recorded a charge of $2.1 million primarily related to the restructuring of our Orthopedic sales force and a voluntary separation arrangement with employees as a result of the COVID-19 pandemic that was charged to selling and administrative expenses based on the nature of the costs and function of the affected employees. During the six months ended June 30, 2021, we recorded a charge of $0.4 million related to the restructuring of our sales force which consisted primarily of termination payments to Orthopedic distributors made in exchange for ongoing assistance to transition to employee-based sales representatives and severance that was charged to selling and administrative expenses.

During the three and six months ended June 30, 2020, we incurred $1.6 million and $3.4 million, respectively, in costs related to the consolidation of certain manufacturing operations which were charged to cost of sales. These costs related to winding down operations at certain locations and moving production lines to other facilities.

During the three and six months ended June 30, 2020, we incurred costs for inventory step-up adjustments and other costs of $0.7 million and $1.5 million, respectively, related to a previous acquisition, which were charged to cost of sales.

During the three and six months ended June 30, 2020, we incurred $0.4 million and $1.2 million, respectively, in severance and integration costs mainly related to the Buffalo Filter acquisition which were included in selling and administrative expense.